doi: 10.1038/s41422-021-00557-y
CNS: Activates satiety signals in the hypothalamus and reduces cravings for high- calorie foods
Methods In this retrospective cohort study, 125 474 adults with overweight or obesity newly initiated treatment with a dual-labeled GLP-1 RA (liraglutide, semaglutide, or tirzepatide) between January 1, 2018, and December 31, 2023, with a baseline body mass index of 27 or more, an available weight measurement within 60 days before initiation, and regular care in the year before initiation were identified using electronic health record data from a collective of US health care systems
Also sold as a dietary supplement in the United States, NAC is gaining popularity due to its powerful antioxidant properties
Patients on GLP-1 medications can lose lean body mass along with fat if protein intake is too low
Always use a fresh needle for each injection rather than reusing, which dulls the tip and increases friction-related irritation